News | November 04, 2024
Briefs: Sun Pharmaceutical Industries and Biocon Biologics
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
The US District Court of New Jersey decided to grant a preliminary injunction delaying the launch of LEQSELVI
To set a new standard in oncology, offering highly targeted radiation therapy that improves treatment precision, and accelerates recovery for cancer patients
Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations
This strong performance was primarily on account of a one-time gain from the strategic collaboration between Biocon Biologics and Eris Lifesciences.
The results are an outcome of the company's focus on sustainable and profitable growth and reflects all the hard work and focus teams have put in over the years
Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
Integrated Disease Surveillance Programme (IDSP) strengthened to improve disease surveillance and rapid data reporting
The academy has secured partnerships with 15 esteemed hospitals
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
Subscribe To Our Newsletter & Stay Updated
